MCHM transdermal gel drug delivery Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MCHM transdermal gel drug delivery

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: terrapin who wrote (369)	3/11/1998 10:38:00 AM
From: Mr Logic	Read Replies (1) of 419

David, Macrochem's strength is in their management, cash, and widely applicable technology IMO. The ultimate end game would be 'SEPA inside' labels on creams. They need to get a move on, but could do well. I don't know about new entrants - Dimethaid has been at this a long while. And the offer to rub nitroglycerine on one's penis gives a whole new meaning to the expression [censored]. The key is real product, approved and getting out of the door. Maybe attention will move to this sector when prices get even more ridiculous in other sectors. I wouldn't say Macrochem is underpriced right now. IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next